Surmet SR

Metformin Hydrochloride 500 mg Sustained Release Tablets

  • Improves glucose tolerance in pateints with type 2 diabets
  • Lowers both basal and postprandial plasma glucose
  • decreases hepatic glucose production
  • Dercreases intensial absorption of glucose
  • improves insulin sensitivity by increasing peripheral glucose uptake and utilization
  • Does not produce hypoglycemia patients with type 2 diabets or normal subjects
  • Insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.